Anika Therapeutics Stock (NASDAQ: ANIK) stock price, news, charts, stock research, profile.
You can purchase shares of Anika Therapeutics (NASDAQ:ANIK) through any online brokerage.
Other companies in Anika Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), Molecular Partners (NASDAQ:MOLN), Renovaro (NASDAQ:RENB), 4D Molecular Therapeutics (NASDAQ:FDMT) and Precigen (NASDAQ:PGEN).
Anika Therapeutics has a consensus price target of $24.50.
The stock price for Anika Therapeutics (NASDAQ: ANIK) is $16.3105 last updated December 20, 2024 at 4:01 PM EST.
There are no upcoming dividends for Anika Therapeutics.
Anika Therapeutics’s Q4 earnings are confirmed for Wednesday, March 12, 2025.
There is no upcoming split for Anika Therapeutics.
Anika Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.